Adopting innovative tech in wound care to meet industry challenges
Will biopharma demand boost customised solutions from NGS informatics providers?
NGS providers prepare for growing Exome and RNA sequencing demand
Cardiac therapies catalysed by next-gen technology
Frost and Sullivan survey possible new Next Generation Sequencing markets
Thriving healthcare markets in Asia and Latin America offer strong growth opportunities for global players
Regenerative medicine research is attracting substantial public and private funding
India's standing in the biotechnology industry is driving rapid growth opportunities, finds report
Drive to increase local drug manufacturing presents opportunities for Ethiopian pharmaceuticals
Patenting activity in pharma sector strongest in China, finds Frost & Sullivan study
New-age technology drives targeted drug delivery
De-risking an increasingly complex chain
Stem cell therapy will redefine regenerative medicine, says F&S
Asia-Pacific healthcare industry shifts towards preventive medicine, finds study
